VA Class:HS051
ATC Class:D07CB01
Triamcinolone acetonide is a synthetic fluorinated corticosteroid.
Triamcinolone shares the actions of the other topical corticosteroids and is used for the relief of the inflammatory manifestations of corticosteroid-responsive dermatoses. The drug is also used as a paste for adjunctive treatment to provide temporary relief of symptoms associated with oral inflammatory or ulcerative lesions resulting from trauma.
For EENT and systemic uses of triamcinolone, see 52:08.08 and 68:04, respectively.
Dermatologic preparations of triamcinolone acetonide are applied sparingly in thin films and are rubbed gently into the affected area 2-4 times daily. The 0.5% cream and 0.5% ointment should be used only in the treatment of dermatoses which are refractory to treatment with lower concentrations. The 0.1 and 0.5% creams are applied 2-3 times daily according to severity of the condition. When the aerosol is applied, an area about the size of the patient's hand is sprayed for about 2 seconds from a distance of about 7.5-15 cm 3 or 4 times daily. Occlusive dressings may be used for severe or resistant dermatoses.
For use in the mouth, a small amount (about 0.6 cm) of the 0.1% paste is pressed to the lesion without rubbing until a thin film develops; a larger amount may be required to cover some lesions. The paste is applied at bedtime and, if necessary, 2 or 3 times daily, preferably after meals. If substantial regeneration or repair of the oral tissues does not occur after 7 days of treatment, further investigation of the etiology of the oral lesions should be undertaken.
Triamcinolone acetonide is a synthetic fluorinated corticosteroid. The drug occurs as a white to cream-colored, crystalline powder having not more than a slight odor and is practically insoluble in water and very soluble in alcohol.
Triamcinolone acetonide cream should be stored at controlled room temperature between 15 and 30°C; freezing and excessive heat should be avoided. Other triamcinolone acetonide preparations should be stored according to the manufacturer's directions.
Additional Information
For further information on chemistry, pharmacology, absorption, uses, cautions, methods of application, and use of occlusive dressings in therapy with triamcinolone, see the Topical Corticosteroids General Statement 84:06.08. The American Society of Health-System Pharmacists, Inc. represents that the information provided in the accompanying monograph was formulated with a reasonable standard of care, and in conformity with professional standards in the field. Readers are advised that decisions regarding use of drugs are complex medical decisions requiring the independent, informed decision of an appropriate health care professional, and that the information contained in the monograph is provided for informational purposes only. The manufacturer's labeling should be consulted for more detailed information. The American Society of Health-System Pharmacists, Inc. does not endorse or recommend the use of any drug. The information contained in the monograph is not a substitute for medical care.
Excipients in commercially available drug preparations may have clinically important effects in some individuals; consult specific product labeling for details.
Please refer to the ASHP Drug Shortages Resource Center for information on shortages of one or more of these preparations.
Routes | Dosage Forms | Strengths | Brand Names | Manufacturer |
---|---|---|---|---|
Topical | Aerosol | 0.2 mg per 2-second spray | Kenalog® Spray | |
Cream | 0.025%* | Aristocort® A | ||
Aristocort® | Astellas | |||
Kenalog® | Sandoz | |||
Triamcinolone Acetonide Topical Cream | ||||
0.1%* | Aristocort® A | Astellas | ||
Aristocort® | Astellas | |||
Kenalog® | Sandoz | |||
Triamcinolone Acetonide Topical Cream | ||||
0.5%* | Aristocort® A | Astellas | ||
Aristocort® | Astellas | |||
Kenalog® | Sandoz | |||
Triamcinolone Acetonide Topical Cream | ||||
Lotion | 0.025%* | Kenalog® | Sandoz | |
0.1%* | Kenalog® | Sandoz | ||
Triamcinolone Acetonide Topical Lotion | ||||
Ointment | 0.025%* | Kenalog® | Sandoz | |
Triamcinolone Acetonide Topical Ointment | ||||
0.1%* | Aristocort® A | Astellas | ||
Aristocort® | Astellas | |||
Kenalog® | Sandoz | |||
Triamcinolone Acetonide Topical Ointment | ||||
0.5% | Aristocort® | Astellas | ||
Kenalog® | Sandoz | |||
Triamcinolone Acetonide Topical Ointment | ||||
Paste | 0.1%* | Kenalog® in Orabase® | Sandoz | |
* available from one or more manufacturer, distributor, and/or repackager by generic (nonproprietary) name
Routes | Dosage Forms | Strengths | Brand Names | Manufacturer |
---|---|---|---|---|
Topical | Cream | 0.1% with Nystatin 100,000 units/g* | Myco® II | |
Mycogen® II | Teva | |||
Mycolog®-II | Sandoz | |||
Myco-Triacet® II | Teva | |||
NGT® | Sandoz | |||
N.T.A.® Cream | ||||
Triamcinolone Acetonide and Nystatin Topical Cream | ||||
Tri-Statin® II | ||||
Ointment | 0.1% with Nystatin 100,000 units/g* | Myco® II | Bioline | |
Mycogen® II | Teva | |||
Mycolog®-II | Sandoz | |||
Myco-Triacet® II | Teva | |||
Mytrex® | Savage | |||
N.T.A.® Ointment | United Research | |||
Triamcinolone Acetonide and Nystatin Topical Cream | ||||
Tri-Statin® II | Rugby |
* available from one or more manufacturer, distributor, and/or repackager by generic (nonproprietary) name